Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults#Seer039s #Proteograph #Platform #Enables #Unprecedented #20000Sample #Proteomics #Study #Korea #University #Develop #AIDriven #Diagnostics #Cancers #Young #Adults